|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 02:55PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
5
|
Resverlogix Corp.
|
Mar 24, 2020 04:33PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 05:00PM
|
|
Re: Resverlogix Presents at Clinical Trials in Alzheimer’s Disease (CTAD) Asia 2018
|
4
|
Resverlogix Corp.
|
Sep 04, 2018 12:33PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
3
|
Resverlogix Corp.
|
Nov 02, 2020 10:15PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
8
|
Resverlogix Corp.
|
Nov 02, 2020 06:37PM
|
|
Re: Righting the (underpowered) vessel
|
7
|
Resverlogix Corp.
|
Oct 31, 2019 05:43PM
|
|
Re: Rules of thumb and broken thumbs...
|
9
|
Resverlogix Corp.
|
Sep 29, 2020 03:47PM
|
|
Re: RVX buyout projection at $30 US minimum
|
1
|
Resverlogix Corp.
|
Nov 01, 2018 09:54PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
4
|
Resverlogix Corp.
|
Jan 09, 2019 04:00PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 04:16PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
6
|
Resverlogix Corp.
|
Jan 08, 2019 04:24PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
3
|
Resverlogix Corp.
|
Jan 09, 2019 01:07PM
|
|
Re: Sanofi Resverlogix connection?
|
1
|
Resverlogix Corp.
|
Jan 13, 2019 10:54PM
|
|
Re: Sedar filings - Loan balance
|
5
|
Resverlogix Corp.
|
Jul 29, 2019 10:20PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
5
|
Resverlogix Corp.
|
Feb 04, 2022 06:08PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
2
|
Resverlogix Corp.
|
Feb 05, 2022 03:11PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
2
|
Resverlogix Corp.
|
Feb 07, 2022 09:54PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
4
|
Resverlogix Corp.
|
Feb 07, 2022 11:42PM
|
|
Re: Shorts
|
3
|
Resverlogix Corp.
|
Aug 15, 2019 02:35PM
|
